<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01202838</url>
  </required_header>
  <id_info>
    <org_study_id>MP125/2008</org_study_id>
    <nct_id>NCT01202838</nct_id>
  </id_info>
  <brief_title>Bioactive Glass Composite Implants in Cranial Bone Reconstruction</brief_title>
  <official_title>Bioactive Glass Composite Implants in Cranial Bone Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study composites of bioactive glass and methylmetacrylate
      with glass fibre reinforcement in cranial bone defect reconstruction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Traditional skull and facial bone reconstructions with hard tissues have a long history with
      good clinical outcomes. However, they have certain disadvantages. The benefits of synthetic
      materials are the avoidance of donor-site morbidity and scars, but also shorter
      hospitalization time, lower expenses and known composition. Custom-made skull bone implant
      can produced based on patients clinical need utilizing rapid prototyping technologies. This
      will result in very high accuracy of the form of the skull defect.

      Polymethylmetacrylate (PMMA) is one of the most widely used alloplastic material in surgery.
      Bioactive glass S53P4 (BAG) particles have been used in various clinical indications. BAG was
      added to composite implant of PMMA with glass fibre reinforcement to enhance bone ingrowth to
      implant, and to utilize BAG`s antimicrobial effects. Ten patients cranial defects are treated
      with composite implants.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2008</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical success</measure>
    <time_frame>3 years</time_frame>
    <description>Clinical success is evaluated using clinical and radiographic examination, and blood count.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Bone Substitutes</condition>
  <arm_group>
    <arm_group_label>Composite Implant</arm_group_label>
    <description>Subject receiving composite implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Composite Implant</intervention_name>
    <description>Subjects receiving composite implants</description>
    <arm_group_label>Composite Implant</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients of Turku university hospital needing cranial bone defect reconstruction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with cranial bone defect larger than 4x4 cm after trauma or tumor surgery

          -  patient signs written study consent

        Exclusion Criteria:

          -  patient is unlikely to adhere to study procedures

          -  patient has a disease or condition that in the opinion of investigator is
             contraindicating participation

          -  patient is participating another medical device or drug trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matti J Peltola, MD, PhD, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matti J Peltola, MD, PhD, DDS</last_name>
    <phone>+35823130000</phone>
    <email>matti.peltola@tyks.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kalle MJ Aitasalo, MD, PhD, DDS</last_name>
    <phone>+35823130000</phone>
    <email>kalle.aitasalo@tyks.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Matti J Peltola, MD, PhD, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Peltola MJ, Aitasalo KM, Aho AJ, Tirri T, Suonpää JT. Long-term microscopic and tissue analytical findings for 2 frontal sinus obliteration materials. J Oral Maxillofac Surg. 2008 Aug;66(8):1699-707. doi: 10.1016/j.joms.2007.11.020.</citation>
    <PMID>18634960</PMID>
  </reference>
  <reference>
    <citation>Peltola M, Aitasalo K, Suonpää J, Varpula M, Yli-Urpo A. Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience. Head Neck. 2006 Sep;28(9):834-41.</citation>
    <PMID>16823870</PMID>
  </reference>
  <reference>
    <citation>Tuusa SM, Peltola MJ, Tirri T, Puska MA, Röyttä M, Aho H, Sandholm J, Lassila LV, Vallittu PK. Reconstruction of critical size calvarial bone defects in rabbits with glass-fiber-reinforced composite with bioactive glass granule coating. J Biomed Mater Res B Appl Biomater. 2008 Feb;84(2):510-9.</citation>
    <PMID>17618510</PMID>
  </reference>
  <reference>
    <citation>Leppäranta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Hupa M, Ylänen H, Salonen JI, Viljanen MK, Eerola E. Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro. J Mater Sci Mater Med. 2008 Feb;19(2):547-51. Epub 2007 Jul 10.</citation>
    <PMID>17619981</PMID>
  </reference>
  <reference>
    <citation>Munukka E, Leppäranta O, Korkeamäki M, Vaahtio M, Peltola T, Zhang D, Hupa L, Ylänen H, Salonen JI, Viljanen MK, Eerola E. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med. 2008 Jan;19(1):27-32. Epub 2007 Jun 14.</citation>
    <PMID>17569007</PMID>
  </reference>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2010</study_first_submitted>
  <study_first_submitted_qc>September 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2010</study_first_posted>
  <last_update_submitted>September 14, 2010</last_update_submitted>
  <last_update_submitted_qc>September 14, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2010</last_update_posted>
  <responsible_party>
    <name_title>Matti Peltola, adjunct professor</name_title>
    <organization>Turku University Hospital</organization>
  </responsible_party>
  <keyword>Cranial bone reconstruction, composite</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

